A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC

Clinical trial NCT04398524 · UNKNOWN

Trial details

NCT number: NCT04398524
Sponsor: ISA Pharmaceuticals
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of the Oropharynx

Start date: 2021-07-01
Primary completion: 2024-06-30
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.